GE Low-Dose Lung Cancer CT Gets FDA Approval

Monday, August 17, 2015

Source: MassDevice

GE Healthcare (NYSE:GE) said today the FDA granted it clearance for low-dose lung cancer screenings using its compatible computed tomography devices.

The Centers for Medicare and Medicaid services recommends the low-dose CT lung cancer screening and approved insurance reimbursement for high-risk patient beneficiaries who undergo the procedure, GE Healthcare said.

View All News »